z-logo
open-access-imgOpen Access
Targeting CXCR4-induced desmoplasia to improve checkpoint inhibition in breast cancer
Author(s) -
George W. Sledge
Publication year - 2019
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.1900368116
Subject(s) - medicine , breast cancer , cancer , oncology , metastatic breast cancer , atezolizumab , cancer research , triple negative breast cancer , lung cancer , targeted therapy , nivolumab , immunotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom